Form 8-K - Current report:
SEC Accession No. 0001193125-22-055857
Filing Date
2022-02-28
Accepted
2022-02-28 08:16:14
Documents
47
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d307069d8k.htm   iXBRL 8-K 27814
2 EX-99.1 d307069dex991.htm EX-99.1 42827
6 GRAPHIC g307069ex99_1p10g1.jpg GRAPHIC 201838
7 GRAPHIC g307069ex99_1p11g1.jpg GRAPHIC 316695
8 GRAPHIC g307069ex99_1p12g1.jpg GRAPHIC 268791
9 GRAPHIC g307069ex99_1p13g1.jpg GRAPHIC 225789
10 GRAPHIC g307069ex99_1p14g1.jpg GRAPHIC 285064
11 GRAPHIC g307069ex99_1p15g1.jpg GRAPHIC 277633
12 GRAPHIC g307069ex99_1p16g1.jpg GRAPHIC 387471
13 GRAPHIC g307069ex99_1p17g1.jpg GRAPHIC 270307
14 GRAPHIC g307069ex99_1p18g1.jpg GRAPHIC 134203
15 GRAPHIC g307069ex99_1p19g1.jpg GRAPHIC 331551
16 GRAPHIC g307069ex99_1p1g1.jpg GRAPHIC 224881
17 GRAPHIC g307069ex99_1p20g1.jpg GRAPHIC 195347
18 GRAPHIC g307069ex99_1p21g1.jpg GRAPHIC 422978
19 GRAPHIC g307069ex99_1p22g1.jpg GRAPHIC 217127
20 GRAPHIC g307069ex99_1p23g1.jpg GRAPHIC 256025
21 GRAPHIC g307069ex99_1p24g1.jpg GRAPHIC 266288
22 GRAPHIC g307069ex99_1p25g1.jpg GRAPHIC 256707
23 GRAPHIC g307069ex99_1p26g1.jpg GRAPHIC 262034
24 GRAPHIC g307069ex99_1p27g1.jpg GRAPHIC 338379
25 GRAPHIC g307069ex99_1p28g1.jpg GRAPHIC 252051
26 GRAPHIC g307069ex99_1p29g1.jpg GRAPHIC 182893
27 GRAPHIC g307069ex99_1p2g1.jpg GRAPHIC 638368
28 GRAPHIC g307069ex99_1p30g1.jpg GRAPHIC 281185
29 GRAPHIC g307069ex99_1p31g1.jpg GRAPHIC 239259
30 GRAPHIC g307069ex99_1p32g1.jpg GRAPHIC 220569
31 GRAPHIC g307069ex99_1p33g1.jpg GRAPHIC 258146
32 GRAPHIC g307069ex99_1p34g1.jpg GRAPHIC 286352
33 GRAPHIC g307069ex99_1p3g1.jpg GRAPHIC 423729
34 GRAPHIC g307069ex99_1p4g1.jpg GRAPHIC 332556
35 GRAPHIC g307069ex99_1p5g1.jpg GRAPHIC 298048
36 GRAPHIC g307069ex99_1p6g1.jpg GRAPHIC 299207
37 GRAPHIC g307069ex99_1p7g1.jpg GRAPHIC 257676
38 GRAPHIC g307069ex99_1p8g1.jpg GRAPHIC 237953
39 GRAPHIC g307069ex99_1p9g1.jpg GRAPHIC 301088
  Complete submission text file 0001193125-22-055857.txt   13499942

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lrmr-20220228.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lrmr-20220228_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lrmr-20220228_pre.xml EX-101.PRE 11266
41 EXTRACTED XBRL INSTANCE DOCUMENT d307069d8k_htm.xml XML 3360
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 22684011
SIC: 2834 Pharmaceutical Preparations